acetylcysteine and Lymphoma, Mantle-Cell

acetylcysteine has been researched along with Lymphoma, Mantle-Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Forte, TM; Ghosh, M; Gordon, LI; Ryan, RO; Singh, AT	1
Schenkein, D	1
Bogner, C; Decker, T; Fend, F; Goetze, K; Häcker, G; Oostendorp, R; Peschel, C; Quintanilla-Martinez, L; Ringshausen, I; Schneller, F	1

Reviews

1 review(s) available for acetylcysteine and Lymphoma, Mantle-Cell

Article	Year
Proteasome inhibitors in the treatment of B-cell malignancies. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Acetylcysteine; Animals; Boronic Acids; Bortezomib; Cell Cycle Proteins; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Enzymes; Gene Expression Regulation; Hodgkin Disease; Humans; Leukemia, B-Cell; Leupeptins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Mice; Multiple Myeloma; Neoplasm Proteins; NF-kappa B; Oncogene Proteins; Peptide Hydrolases; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Substrate Specificity; Transcription Factors; Treatment Outcome	2002

Article

Year

Proteasome inhibitors in the treatment of B-cell malignancies.

Clinical lymphoma, 2002, Volume: 3, Issue:1

Topics: Acetylcysteine; Animals; Boronic Acids; Bortezomib; Cell Cycle Proteins; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Enzymes; Gene Expression Regulation; Hodgkin Disease; Humans; Leukemia, B-Cell; Leupeptins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Mice; Multiple Myeloma; Neoplasm Proteins; NF-kappa B; Oncogene Proteins; Peptide Hydrolases; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Substrate Specificity; Transcription Factors; Treatment Outcome

2002

Other Studies

2 other study(ies) available for acetylcysteine and Lymphoma, Mantle-Cell

Article	Year
Curcumin nanodisk-induced apoptosis in mantle cell lymphoma. Leukemia & lymphoma, 2011, Volume: 52, Issue:8 Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Curcumin; Cyclin D1; Dose-Response Relationship, Drug; Drug Delivery Systems; Flow Cytometry; G1 Phase; Humans; Lymphoma, Mantle-Cell; Nanostructures; Nanotechnology; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species	2011
Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells. British journal of haematology, 2003, Volume: 122, Issue:2 Topics: Acetylcysteine; Apoptosis; B-Lymphocytes; Blotting, Western; Caspase 3; Caspase 9; Caspases; CD4-Positive T-Lymphocytes; Cell Cycle; Humans; In Situ Nick-End Labeling; Lymphoma, Mantle-Cell; Protease Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2003

Article

Year

Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.

Leukemia & lymphoma, 2011, Volume: 52, Issue:8

Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Curcumin; Cyclin D1; Dose-Response Relationship, Drug; Drug Delivery Systems; Flow Cytometry; G1 Phase; Humans; Lymphoma, Mantle-Cell; Nanostructures; Nanotechnology; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species

2011

Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.

British journal of haematology, 2003, Volume: 122, Issue:2

Topics: Acetylcysteine; Apoptosis; B-Lymphocytes; Blotting, Western; Caspase 3; Caspase 9; Caspases; CD4-Positive T-Lymphocytes; Cell Cycle; Humans; In Situ Nick-End Labeling; Lymphoma, Mantle-Cell; Protease Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003